Le Lézard
Classified in: Health
Subject: MIN

Shady Grove Fertility's (SGF) Center for Male Fertility supports Men's Health Awareness Month this November with free patient resources


SGF's Center for Male Fertility encourages fertility preservation before cancer treatment and provides mental health resources for men.

ROCKVILLE, Md., Nov. 7, 2022 /PRNewswire-PRWeb/ -- Shady Grove Fertility's Center for Male Fertility supports Men's Health Awareness month by providing free patient resources for men facing infertility.

Men's Health Awareness Month occurs every November to heighten awareness and provide education about cancers specific to men as well as men's mental health. Separate from Men's Health Month recognized in June, November's Men's Health Awareness Month raises awareness of, and support for, men coping with prostate cancer, testicular cancer, and mental health issues.

SGF's Center for Male Fertility, comprised of reproductive urologists Paul Shin, M.D., Cori Tanrikut, M.D., and Russel Hayden, M.D., encourages male fertility preservation prior to cancer treatment in order to secure future family-building options. Similar to egg and embryo freezing, men can freeze their sperm to preserve fertility when faced with testicular tumors or other cancers. Cryopreservation of sperm is a viable option for men to safeguard their fertility prior to undergoing cancer treatments.

"While fertility issues are often directly associated with women, that just isn't reality," shares Dr. Shin. "Between 40 and 50 percent of infertility cases are due to male-factor infertility. Dealing with infertility can be a stressful experience for all involved and SGF's Center for Male Fertility seeks to break the stigma around men's fertility health, so men can find the support resources they may need."

In addition to male fertility preservation, SGF's Center for Male Fertility offers a range of male services from basic fertility evaluation and testing to surgical interventions and state-of-the-art microsurgical techniques, including:

 

Nearly one in eight couples will face infertility, understandably resulting in possible medical, emotional, physical, and financial stress. SGF offers a wide array of free resources for men seeking more knowledge on reproductive health, such as:

 

 

To schedule an appointment with one of our reproductive urologists, or any of SGF's reproductive endocrinologists, call 1-888-761-1967 or complete this brief online request form.

About Shady Grove Fertility (SGF)
SGF is a leading fertility and IVF center of excellence with more than 100,000 babies born from 30+ years of continuous innovation and patient-centered fertility care. With over 50 locations throughout the U.S. and in Santiago, Chile, SGF accepts most insurance plans and makes fertility treatment accessible and affordable through innovative financial solutions, including 100% refund guarantees. SGF is among the founding partner practices of US Fertility, the largest physician-owned and physician-led partnership of top-tier fertility practices nationally. Call 1-888-761-1967 to schedule a new patient appointment or visit ShadyGroveFertility.com for more information.

Media Contact

Jean Dzierzak, Shady Grove Fertility, 301-545-1375, [email protected]

Twitter

 

SOURCE Shady Grove Fertility


These press releases may also interest you

at 18:07
A new guideline has been issued to help neurologists and other clinicians determine the best antiseizure medications for people with epilepsy who may become pregnant. The guideline is published in the May 15, 2024, online issue of Neurology®, the...

at 18:00
The leading cause of death worldwide is chronic inflammatory diseases. When the body is inflamed and under stress for long periods of time, the body's heart rate increases, increasing the risk of fatality. A new study published in Brain, Behavior and...

at 17:55
The global gas chromatography market  size is estimated to grow by USD 1042.59 mn from 2023-2027, according to Technavio. The market is estimated to grow at a CAGR of  7.14%  during the forecast period. ...

at 17:50
Blue Cross Blue Shield of Michigan's Board of Directors today appointed Tricia A. Keith as president and CEO-Elect. Ms. Keith, 53, will succeed Daniel J. Loepp as president and CEO following his retirement on January 1, 2025. She will become the...

at 17:45
Quest Diagnostics , a leader in diagnostic information services, today announced that its Board of Directors declared a quarterly cash dividend of $0.75 per share, payable on July 22, 2024 to shareholders of record of Quest Diagnostics common stock...

at 17:05
Veracyte, Inc. a leading cancer diagnostics company, today announced it will participate in the following investor conferences. Leerink Partners 2024 Healthcare Crossroads Conference ? Austin, TX Fireside Chat on May 29th at 12:20 p.m. Eastern...



News published on and distributed by: